Virtu Financial LLC Viking Therapeutics, Inc. Transaction History

Virtu Financial LLC

$1.89 Billion
Q4 2024

A detailed history of Virtu Financial LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 42,613 shares of VKTX stock, worth $1.45 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

42,613

Holding current value

$1.45 Million

% of portfolio

0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$38.28 - $78.03 $1.63 Million - $3.33 Million	42,613 New	42,613 $1.72 Million
Q2 2024 Aug 09, 2024	BUY	$47.39 - $80.2 $1.31 Million - $2.21 Million	27,569 New	27,569 $1.46 Million
Q4 2023 Feb 26, 2024	BUY	$9.24 - $19.64 $35,721 - $75,928	3,866 Added 15.14%	29,394 $547,000
Q3 2023 Nov 14, 2023	SELL	$10.92 - $16.0 $575,494 - $843,216	-52,701 Reduced 67.37%	25,528 $283,000
Q2 2023 Jul 27, 2023	BUY	$14.84 - $24.79 $1.16 Million - $1.94 Million	78,229 New	78,229 $1.27 Million
Q3 2022 Nov 07, 2022	BUY	$2.55 - $3.89 $43,199 - $65,900	16,941 New	16,941 $46,000
Q1 2022 May 17, 2022	SELL	$3.0 - $4.88 $37,899 - $61,649	-12,633 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$4.6 - $6.72 $58,111 - $84,893	12,633 New	12,633 $58,000
Q3 2021 Nov 12, 2021	SELL	$5.58 - $7.04 $127,943 - $161,420	-22,929 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$5.19 - $6.73 $119,001 - $154,312	22,929 New	22,929 $137,000
Q1 2021 May 19, 2021	SELL	$5.74 - $9.67 $213,252 - $359,259	-37,152 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$5.3 - $6.71 $196,905 - $249,289	37,152 New	37,152 $209,000
Q3 2020 Dec 11, 2020	SELL	$5.73 - $8.11 $73,120 - $103,491	-12,761 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$4.35 - $8.08 $55,510 - $103,108	12,761 New	12,761 $92,000
Q4 2019 Feb 04, 2020	SELL	$6.38 - $8.73 $77,012 - $105,379	-12,071 Closed	0 $0
Q3 2019 Nov 20, 2019	SELL	$6.55 - $8.6 $53,480 - $70,219	-8,165 Reduced 40.35%	12,071 $83,000
Q2 2019 Aug 13, 2019	SELL	$7.67 - $10.63 $1.1 Million - $1.53 Million	-143,546 Reduced 87.64%	20,236 $168,000
Q1 2019 Apr 12, 2019	BUY	$7.58 - $9.94 $1.11 Million - $1.46 Million	146,438 Added 844.32%	163,782 $1.63 Million
Q4 2018 Jan 16, 2019	SELL	$7.16 - $16.21 $69,659 - $157,707	-9,729 Reduced 35.94%	17,344 $133,000
Q3 2018 Nov 13, 2018	BUY	$9.7 - $19.65 $262,608 - $531,984	27,073 New	27,073 $472,000
Q2 2018 Jul 30, 2018	SELL	$3.88 - $12.74 $219,348 - $720,230	-56,533 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$3.88 - $12.74 $219,348 - $720,230	56,533 New	56,533 $536,000
Q4 2017 Feb 09, 2018	SELL	$1.74 - $4.34 $63,663 - $158,791	-36,588 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$0.94 - $1.91 $34,392 - $69,883	36,588	36,588 $0

Others Institutions Holding VKTX

# of Institutions

466

Shares Held

65.8M

Call Options Held

5.84M

Put Options Held

3.76M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.61B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account

Virtu Financial LLC Viking Therapeutics, Inc. Transaction History